Celestica (CLS) director Kulvinder Ahuja awarded 133 restricted share units

Rhea-AI Filing Summary

Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.

CELESTICA INC director Kulvinder Ahuja received an equity grant. On August 11, 2026, Ahuja was granted 133 Director Restricted Share Units (D‑RSUs), each representing a contingent right to receive one common share or an equivalent cash value at the issuer’s election. These D‑RSUs vest on May 20, 2027, and Ahuja now holds 700 D‑RSUs in total on a direct basis.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ahuja Kulvinder

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Director Restricted Share Units F1, F2	133	$0.00	$0.00

Holdings After Transaction: Director Restricted Share Units — 700 shares (Direct)

Footnotes (2)

1. F1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.
2. F2. On August 11, 2026, the reporting person was granted 133 D-RSUs, which vest on May 20, 2027.

Key Figures

D‑RSUs granted: 133 Director Restricted Share Units D‑RSUs held after grant: 700 Director Restricted Share Units Grant price per D‑RSU: $0.0000 per unit +1 more

4 metrics

D‑RSUs granted 133 Director Restricted Share Units Grant to director Kulvinder Ahuja on August 11, 2026

D‑RSUs held after grant 700 Director Restricted Share Units Total direct holdings following the reported transaction

Grant price per D‑RSU $0.0000 per unit Stated transaction price for the award acquisition

Vesting date May 20, 2027 Vesting date for the 133 D‑RSUs granted on August 11, 2026

Key Terms

Director Restricted Share Units, contingent right, deferral election

3 terms

Director Restricted Share Units financial

"Each director restricted share unit ("D-RSU") represents a contingent right"

contingent right financial

"represents a contingent right to receive one common share upon settlement"

deferral election financial

"upon settlement, subject to the reporting person's deferral election"

FAQ

What insider transaction did CELESTICA INC (CLS) report for Kulvinder Ahuja?

CELESTICA INC reported that director Kulvinder Ahuja received a grant of 133 Director Restricted Share Units on August 11, 2026, as part of equity-based compensation.

How many Director Restricted Share Units were granted to the CLS director?

Director Kulvinder Ahuja was granted 133 Director Restricted Share Units (D‑RSUs). Each D‑RSU is a contingent right to receive one common share or an equivalent cash amount upon settlement.

When do the newly granted D‑RSUs for CELESTICA INC (CLS) vest?

The 133 D‑RSUs granted to director Kulvinder Ahuja vest on May 20, 2027. Vesting is a condition that must be met before common shares or cash can be delivered.

What does each Director Restricted Share Unit represent for CLS?

Each CLS Director Restricted Share Unit represents a contingent right to receive one common share upon settlement, subject to any deferral election, or an equivalent cash value at CELESTICA INC’s election.

How many Director Restricted Share Units does the CLS director hold after this grant?

After this grant, director Kulvinder Ahuja holds a total of 700 Director Restricted Share Units directly, including the 133 D‑RSUs granted on August 11, 2026.

Is the reported CLS insider transaction a market purchase or sale?

No, the reported transaction is a grant/award acquisition of 133 D‑RSUs at a stated price of $0.0000 per unit, rather than an open-market purchase or sale of common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 04:45 PM Accepted by SEC EDGAR 08/12/2026 - 04:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ahuja Kulvinder

(Last) (First) (Middle)

5140 YONGE STREET

SUITE 1900

(Street)

TORONTO M2N 6L7

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Restricted Share Units	(1)	08/11/2026		A		133		(2)	(2)	Common Shares	133	$0	700	D

Explanation of Responses:

1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.

2. On August 11, 2026, the reporting person was granted 133 D-RSUs, which vest on May 20, 2027.

	/s/ Tracy Connelly McGilley, attorney-in-fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)